Schedule 13G ownership disclosure
AMRYT PHARMA LTD - SPNR ADR
Security class unavailable · CUSIP: 03217L106
Event date: 2020-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 24,698,833
- Percent of class
- 9.9900%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000902664-21-000891
- Form type
- SC 13G
- Filer
- Amryt Pharma plc
- CIK
- CIK 1783010
- Filed
- Feb 05, 2021
- Reporting period
- Dec 31, 2020
- Description
- Schedule 13G beneficial ownership